The Synergistic Role of Tea and Nigella Sativa in Ocular Health: Antioxidant Strategies Against Oxidative Stress

Oxidative stress plays a pivotal role in the development and progression of major ocular diseases such as glaucoma, cataracts, and age-related macular degeneration (AMD), all of which contribute significantly to vision loss and blindness among the elderly. Addressing this pathogenic mechanism is critical for advancing preventive and therapeutic strategies. Among the array of natural antioxidants, tea (with a particular emphasis on green tea) and Nigella sativa (black seed) have emerged as highly promising due to their unique biochemical profiles and potent biological activities. Green tea is especially noted for its rich content of polyphenolic flavonoids—including catechins such as Epicatechin (EC), Epigallocatechin (EGC), Epicatechin-3-Gallate (ECG), and Epigallocatechin-3-Gallate (EGCG). These bioactive molecules, preserved in high concentrations by the minimal oxidation processing of green tea, have demonstrated powerful antioxidant activity. The mechanisms by which these catechins combat oxidative stress are relevant for mitigating cellular and tissue damage within the ocular system. Similarly, Nigella sativa is renowned for its major constituent, thymoquinone, which has been demonstrated to exert robust antioxidant, anti-inflammatory, and neuroprotective effects. These properties are particularly valuable in reducing ocular tissue injury and slowing the progression of degenerative eye diseases. The significance of focusing on tea and Nigella sativa as antioxidant sources lies in their complementary mechanisms of action and their proven efficacy in reducing oxidative damage in various models. Together, these natural compounds present a synergistic and accessible dietary intervention for the prevention and management of vision-threatening ocular diseases linked to oxidative stress. This review underscores the importance of leveraging the complementary mechanisms of tea and Nigella sativa in mitigating oxidative stress-related ocular pathologies and advocates for further research to explore their combined therapeutic efficacy